ZIOP insider trading
CIK 1107421ZIOPHARM ONCOLOGY INC: insider trade history from SEC Form 4 filings.
ZIOP insider activity at a glance
FilingIQ tracks 201 insider transactions for ZIOP in filings since Jan 2, 2015. The most recent transaction is dated Dec 22, 2021. They were reported by 31 insiders.
Across the full history, 11 open-market purchases
and 20 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest ZIOP Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Tickers with similar insider activity
Ranked next to ZIOP by Form 4 lines in the last 90 days, the number on each card.
Politicians who have traded ZIOP
Frequently asked
- How many insider trades does FilingIQ track for ZIOP?
- FilingIQ tracks 201 Form 4 insider transactions for ZIOP (ZIOPHARM ONCOLOGY INC), covering filings from Jan 2, 2015 onwards. 0 of those are dated within the last 90 days.
- Are ZIOP insiders net buyers or net sellers?
- Across the full Form 4 history for ZIOP, 11 transactions (5%) were open-market purchases and 20 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ZIOP insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
Methodology & sources
Every ZIOP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.